Abstract
Psychiatry is increasingly combining new pharmacogenomic findings with therapeutic drug monitoring (TDM) to improve the safety and efficacy of pharmacotherapy. However, a distinction should be made between "nice to know" and "need to know" pharmacogenomic data because many results are statistically significant in meta-analyses but are not clinically relevant due to their low effect sizes. Some examples will illustrate this integration.
| Original language | English |
|---|---|
| Pages (from-to) | 254-257 |
| Number of pages | 4 |
| Journal | Clinical Pharmacology and Therapeutics |
| Volume | 95 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2014 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)